Detalles de la búsqueda
1.
Effect of immune-modulating metronomic capecitabine as an adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma.
BMC Immunol
; 25(1): 28, 2024 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38710996
2.
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial.
Lancet
; 398(10297): 303-313, 2021 07 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34111416
3.
[Phase II clinical trial of two different modes of administration of the induction chemotherapy for locally advanced nasopharyngeal carcinoma].
Zhonghua Zhong Liu Za Zhi
; 37(9): 676-81, 2015 Sep.
Artículo
en Zh
| MEDLINE | ID: mdl-26813432
4.
Long-term survival, toxicities, and the role of chrono-chemotherapy with different infusion rates in locally advanced nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy: a retrospective study with a 5-year follow-up.
Front Oncol
; 14: 1371878, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38585011
5.
A prospective phase II randomized study of docetaxel combined with lobaplatin versus TPF regimen induction chemotherapy followed by concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma.
J Cancer Res Clin Oncol
; 149(20): 18081-18091, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37985501
6.
The Treatment Combining Antiangiogenesis with Chemoradiotherapy Impinges on the Peripheral Circulation Vascular Endothelial Cells and Therapeutic Effect in the Patients with Locally Advanced Nasopharyngeal Carcinoma.
Biomed Res Int
; 2022: 1787854, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35872851
7.
Downregulation of the circadian Period family genes is positively correlated with poor head and neck squamous cell carcinoma prognosis.
Chronobiol Int
; 36(12): 1723-1732, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31609143
Resultados
1 -
7
de 7
1
Próxima >
>>